Adroit Biomed Limited

Pharmaceutical company specializing in dermato-cosmetology products for hair, skin, and oral care.

2009 | Mumbai, Maharashtra (India) | Active
Last Updated: July 05, 2024

Adroit Biomed Profile

Key Indicators

  • Authorised Capital ₹ 2.50 Cr
  • Paid Up Capital ₹ 4.25 M
  • Company Age 15 Year, 1 Month
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 2.75 Cr
  • Revenue Growth 27.82%
  • Profit Growth -6.19%
  • Ebitda -12.53%
  • Net Worth 29.56%
  • Total Assets 7.63%

About Adroit Biomed

Adroit Biomed Limited (ABL) is a leading Public Limited Indian Non-Government Company incorporated in India on 10 December 2009 and has a history of 15 years and one month. Its registered office is in Mumbai, Maharashtra, India.

The Corporate was formerly known as Adroit Biomed Private Limited. The Company is engaged in the Fmcg Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 4.25 M.

The company currently has active open charges totaling ₹2.75 Cr.

Darshak Shah, Jagjeet Ahluwalia, Sushant Raorane, and Six other members serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U22100MH2009PLC197761

  • Company No.

    197761

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    10 Dec 2009

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

FMCG
Pharma

What products or services does Adroit Biomed Limited offer?

Adroit Biomed Limited offers a wide range of products and services, including Face Cream, Fairness Cream, Skin Creams, Beauty Cream, Beauty Services, Gold Facial, Hair Care Products.

Who are the key members and board of directors at Adroit Biomed?

Board Members (9)

Name Designation Appointment Date Status
Darshak Shah Country flag representing In Director 03-May-2017 Current
Ajit Marathe Country flag representing In Director 19-Oct-2010 Current
Jagjeet Ahluwalia Country flag representing Gb Director 24-Jul-2018 Current
Sushant Raorane Country flag representing In Director 19-Oct-2010 Current
Manish Bhachoo Country flag representing In Director 03-May-2017 Current
Anil Sharma Country flag representing Io Director 13-Jul-2017 Current

Financial Performance of Adroit Biomed.

Adroit Biomed Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.82% increase. The company also saw a slight decrease in profitability, with a 6.19% decrease in profit. The company's net worth Soared by an impressive increase of 29.56%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
27.82%
Revenue from Operations
27.43%
Total Assets
7.63%
Profit or Loss
-6.19%
Net Worth
29.56%
EBITDA
-12.53%

What is the Ownership and Shareholding Structure of Adroit Biomed?

In 2023, Adroit Biomed had a promoter holding of 81.82% and a public holding of 18.17%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹2.75 Cr

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Others : 2.75 Cr

Latest Charge Details

Date Lender Amount Status
21 Apr 2013 Others ₹2.75 Cr Open

How Many Employees Work at Adroit Biomed?

Adroit Biomed has a workforce of 135 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Adroit Biomed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adroit Biomed's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Adroit Biomed

Recent activity within the organization

  • Annual General Meeting

    Adroit Biomed Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Balance Sheet

    Adroit Biomed Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.

    31 Mar 2023

  • Director Appointment

    Jagjeet Kaur Ahluwalia was appointed as a Director was appointed as a Director on 24 Jul 2018 & has been associated with this company since 6 years 6 months .

    24 Jul 2018

  • Director Appointment

    Anil Kumar Sharma was appointed as a Director was appointed as a Director on 13 Jul 2017 & has been associated with this company since 7 years 6 months .

    13 Jul 2017

  • Director Appointment

    Darshak Jitendra Shah was appointed as a Director was appointed as a Director on 03 May 2017 & has been associated with this company since 7 years 9 months .

    03 May 2017

  • Director Appointment

    Manish Jaswantsingh Bhachoo was appointed as a Director was appointed as a Director on 03 May 2017 & has been associated with this company since 7 years 9 months .

    03 May 2017

Frequently asked questions

  • Adroit Biomed Limited was incorporated on 10 Dec 2009.

  • The authorized share capital of Adroit Biomed Limited is ₹ 2.50 Cr and paid-up capital is ₹ 4.25 M.

  • Currently 9 directors are associated with Adroit Biomed Limited.

    • Darshak Jitendra Shah
    • Jagjeet Kaur Ahluwalia
    • Sushant Shashikant Raorane
    • Manish Jaswantsingh Bhachoo
    • Anil Kumar Sharma
    • Jitesh Pramodkumar Agrawal
    • Ajit Shriniwas Marathe
    • Sameer Ashok Paigankar
    • Ramesh Ranchhodbhai Madat
  • As per Ministry of Corporate Affairs (Mca), the registered address of Adroit Biomed Limited is Unit No F-115 1St Floor Kanakia Zillion Bkc Annexure Lbs/Cst Road Kurla (West), Mumbai, Maharashtra, India, 400070.

  • The corporate identification number (CIN) of Adroit Biomed Limited is U22100MH2009PLC197761 and the company number is 197761 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Adroit Biomed Limited is https://www.adroitbiomed.com

  • According to the financial reports for the fiscal year 2023, the revenue trend for Adroit Biomed Limited has risen by 27.82%.

  • As Per 2023 financial reports, 135 employees are currently employed by Adroit Biomed Limited.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Adroit Biomed Limited has experienced an upsurge of 29.56%.

  • As per the financial statements for fiscal Year 2023, The total open charges for Adroit Biomed Limited amount to ₹ 2.75 Cr.

  • The most recent Balance Sheet for Adroit Biomed Limited was filed with the ROC on 31 Mar 2023.

Similar Companies Based on Pharmaceutical Retailers & Distributors